Alzheimer’s disease affects more than 6 million people in the United States, and there are very few FDA-approved treatments that can slow the progression of the disease. In hopes of discovering new targets for potential Alzheimer’s treatments, MIT researchers have performed the broadest analysis yet of the genomic, epigenomic, and transcriptomic changes that occur in every cell type in the brains of Alzheimer’s patients. Using more than 2 million cells from more than 400 postmortem...
Read more
Computer News: Decoding the complexity of Alzheimer’s disease
- bob_turner
- Bedrock
- Posts: 87604
- Joined: Fri May 25, 2018 5:14 pm
- 6
- Mood: